Know Before You Go: AI in 2026 — Signals, Risks, and Real-World Impact

​This must-attend webinar will cover all the topics and trends you need to know about AI & Biopharma in advance of JP Morgan Healthcare Conference Week in San Francisco, Jan 11-15, 2026 (#JPM2026).

​🎙️ Hosted by Dr. Sophia Ononye

​Dr. Ononye brings unmatched credibility and reach to every conversation. As host of Amplifying Scientific Innovation®, she combines scientific rigor, public health insight, and business acumen to elevate each discussion.

​We’ll explore:

• ​Key AI and data trends expected to influence JPM 2026 conversations

• ​Lessons from 2025 that will guide next-year partnerships

• ​How human-AI collaboration is reshaping innovation and investment

• ​Practical insights for leaders navigating this evolving landscape

​Confirmed Panelists:

⦁ Dr. Karen Knudsen, CEO of the Parker Institute

​⦁ Dan Gober, Executive Director, Biocom California

​⦁ Dr. Saudat Fadeyi, Head of Business Development, Samyang Biopharm USA, Inc.

​⦁ Martha Lawrence, CEO & Co-Founder of AccendoWave

​⦁ Dr. Amit Gir, CEO & Co-Founder of Phox Health


This inaugural session of the AI in Biopharma 2026 Webinar Series explores how AI is transforming clinical trials, patient care, drug discovery, and data responsibility — while examining the critical intersections with privacy, ethics, and human trust.